Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bioavailability Study Design: Absolute Versus Relative Bioavailability01:27

Bioavailability Study Design: Absolute Versus Relative Bioavailability

227
Bioavailability is a crucial pharmacokinetic parameter that quantifies the proportion of an administered drug that reaches the systemic circulation and is available for therapeutic action. Regulatory agencies mandate the assessment of bioavailability, typically measured as the area under the drug plasma concentration-versus-time curve (AUC), to ensure the efficacy and safety of pharmaceutical products. These evaluations are categorized as absolute and relative bioavailability studies.Absolute...
227
Measurement of Bioavailability: Pharmacokinetic Methods01:30

Measurement of Bioavailability: Pharmacokinetic Methods

181
Pharmacokinetics is a vital branch of pharmacology that examines how drugs are absorbed, distributed, metabolized, and excreted by the body. Two key methodologies in pharmacokinetics are plasma drug concentration studies and urinary drug excretion analyses, both of which provide critical insights into a drug's therapeutic efficacy and bioavailability.Plasma Drug Concentration-Time StudiesPlasma drug concentration-time studies involve analyzing blood samples at specific intervals to quantify...
181
Measurement of Bioavailability: Pharmacodynamic Methods01:20

Measurement of Bioavailability: Pharmacodynamic Methods

160
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
160
Bioavailability Study Design: Single Versus Multiple Dose Studies01:11

Bioavailability Study Design: Single Versus Multiple Dose Studies

143
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
143
Bioavailability: Overview01:13

Bioavailability: Overview

3.8K
Bioavailability refers to the proportion of an unaltered drug that, after administration, enters the systemic circulation and can be distributed to the desired action site. Factors such as gastrointestinal (GI) absorption and liver biotransformation influence the bioavailability of a drug when it is administered orally. When a drug is administered intravenously, it enters the systemic circulation directly; by definition, its bioavailability is assumed to be 100%. The bioavailability of an...
3.8K
Bioavailability: Overview01:17

Bioavailability: Overview

269
Bioavailability refers to the proportion of an administered drug that reaches the systemic circulation in its active, unaltered form. It is a crucial pharmacokinetic parameter that determines the effectiveness of a drug in achieving its intended therapeutic outcomes. The route of administration significantly influences bioavailability, with intravenous administration achieving 100% bioavailability as the drug directly enters the bloodstream. In contrast, oral administration often results in...
269

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Pilot, Single-Blinded, Randomized Crossover Trial of Cramp Reduction with Angiotensin II in Maintenance Patients on Hemodialysis (the CRAMP-HD Study).

American journal of nephrology·2025
Same author

Tribute: Sir Colin Terence Dollery, MB, Ch, MD (Hon).

Clinical pharmacology and therapeutics·2021
Same author

Tribute: Marcus M. Reidenberg, MD.

Clinical pharmacology and therapeutics·2020
Same author

A Survey on Dialysis-Related Muscle Cramping and a Hypothesis of Angiotensin II on Its Pathophysiology.

Kidney international reports·2020
Same author

Intracerebroventricular drug administration.

Translational and clinical pharmacology·2020
Same author

Elucidation of the pathophysiology of intradialytic muscle cramps: pharmacokinetics applied to translational research.

Translational and clinical pharmacology·2020
Same journal

Exploratory comparative pharmacokinetic study of a fixed-dose combination of telmisartan/amlodipine/chlorthalidone: half-dose (20/2.5/6.25 mg) versus conventional dose (40/5/12.5 mg).

Translational and clinical pharmacology·2026
Same journal

Comparative pharmacokinetics of a candesartan/amlodipine/atorvastatin fixed-dose combination 8 mg/5 mg/10 mg versus separate tablets in healthy subjects: a partial replicated crossover study.

Translational and clinical pharmacology·2026
Same journal

Erratum: A review of clinical pharmacology considerations in antibody-drug conjugates approved by the US Food and Drug Administration between 2000 and 2025.

Translational and clinical pharmacology·2026
Same journal

The pH factor: unraveling drug-drug interactions in protein kinase inhibitors through the regulatory lens.

Translational and clinical pharmacology·2026
Same journal

Pioneering pharmacometrics practice in Korea: an eight-year retrospective analysis of 192 projects from the first dedicated service organization (2016-2024).

Translational and clinical pharmacology·2026
Same journal

Incidence and sex-related risk factors of linezolid-associated adverse drug reactions identified through electronic health records.

Translational and clinical pharmacology·2026
See all related articles

Related Experiment Video

Updated: Dec 27, 2025

The Caco-2 Cell Bioassay for Measurement of Food Iron Bioavailability
06:34

The Caco-2 Cell Bioassay for Measurement of Food Iron Bioavailability

Published on: April 28, 2022

5.4K

The stable isotope method for determining absolute bioavailability.

Arthur J Atkinson1

  • 1Department of Pharmacology, Feinberg School of Medicine, Northwestern University Chicago, Illinois, USA.

Translational and Clinical Pharmacology
|March 6, 2020
PubMed
Summary
This summary is machine-generated.

Drug bioavailability can change significantly in patients with liver disease or reduced blood flow. Further research is needed for special populations like children and pregnant women.

Keywords:
Absolute bioavailabilityPatient studiesPharmacokineticsStable isotopes

More Related Videos

Stable Isotopic Profiling of Intermediary Metabolic Flux in Developing and Adult Stage Caenorhabditis elegans
12:10

Stable Isotopic Profiling of Intermediary Metabolic Flux in Developing and Adult Stage Caenorhabditis elegans

Published on: February 27, 2011

13.9K
A Method for Measuring Metabolism in Sorted Subpopulations of Complex Cell Communities Using Stable Isotope Tracing
07:41

A Method for Measuring Metabolism in Sorted Subpopulations of Complex Cell Communities Using Stable Isotope Tracing

Published on: February 4, 2017

8.8K

Related Experiment Videos

Last Updated: Dec 27, 2025

The Caco-2 Cell Bioassay for Measurement of Food Iron Bioavailability
06:34

The Caco-2 Cell Bioassay for Measurement of Food Iron Bioavailability

Published on: April 28, 2022

5.4K
Stable Isotopic Profiling of Intermediary Metabolic Flux in Developing and Adult Stage Caenorhabditis elegans
12:10

Stable Isotopic Profiling of Intermediary Metabolic Flux in Developing and Adult Stage Caenorhabditis elegans

Published on: February 27, 2011

13.9K
A Method for Measuring Metabolism in Sorted Subpopulations of Complex Cell Communities Using Stable Isotope Tracing
07:41

A Method for Measuring Metabolism in Sorted Subpopulations of Complex Cell Communities Using Stable Isotope Tracing

Published on: February 4, 2017

8.8K

Area of Science:

  • Pharmacokinetics
  • Drug Metabolism
  • Clinical Pharmacology

Background:

  • Drug bioavailability is typically evaluated in healthy individuals.
  • Patient populations and special groups may experience altered drug bioavailability.
  • Limited research exists on bioavailability changes in non-healthy subjects.

Purpose of the Study:

  • To investigate potential alterations in drug bioavailability in patient populations.
  • To compare absolute bioavailability between healthy subjects and patients.
  • To identify factors influencing drug bioavailability in specific demographic groups.

Main Methods:

  • Utilized the stable isotope method for comparative bioavailability studies.
  • Compared absolute bioavailability in patients versus healthy controls.
  • Focused on patient groups with specific disease states and special populations.

Main Results:

  • Significant changes in drug bioavailability were observed in patients with advanced liver disease.
  • Reduced splanchnic blood flow was associated with altered drug bioavailability.
  • Bioavailability differences are anticipated in neonates, children, and pregnant women compared to adults.

Conclusions:

  • Drug bioavailability is not constant across all populations and can be significantly impacted by disease states.
  • Patients with compromised liver function or reduced blood flow require careful consideration of drug dosing.
  • Further studies are essential to understand and manage drug bioavailability in pediatric and obstetric populations.